Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$25.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Stallergenes SA Announces FDA Acceptance For Review Of BLA For Oralair


Monday, 18 Feb 2013 02:00am EST 

Stallergenes SA announced that FDA has accepted for review Biologics License Application (BLA) for Oralair, five-grass pollen extract allergen immunotherapy (AIT) sublingual tablet. 

Company Quote

50.5
-0.5 -0.98%
24 Oct 2014